These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16518761)

  • 21. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
    Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
    Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunopathogenesis of cerebral malaria.
    Hunt NH; Golenser J; Chan-Ling T; Parekh S; Rae C; Potter S; Medana IM; Miu J; Ball HJ
    Int J Parasitol; 2006 May; 36(5):569-82. PubMed ID: 16678181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the course and outcome of blood-stage malaria by erythropoietin-induced reticulocytosis.
    Chang KH; Tam M; Stevenson MM
    J Infect Dis; 2004 Feb; 189(4):735-43. PubMed ID: 14767829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin in stroke: quo vadis.
    Digicaylioglu M
    Expert Opin Biol Ther; 2010 Jun; 10(6):937-49. PubMed ID: 20394473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats.
    Cherian L; Goodman JC; Robertson C
    J Pharmacol Exp Ther; 2007 Aug; 322(2):789-94. PubMed ID: 17470644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin does not attenuate cytokine production and inflammation in microglia--implications for the neuroprotective effect of erythropoietin in neurological diseases.
    Wilms H; Schwabedissen B; Sievers J; Lucius R
    J Neuroimmunol; 2009 Jul; 212(1-2):106-11. PubMed ID: 19464738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene-knockout mice in malaria research: useful or misleading?
    Hernandez-Valladares M; Naessens J; Iraqi FA
    Trends Parasitol; 2007 Nov; 23(11):522-6. PubMed ID: 17951110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin and neuroprotection: a therapeutic perspective.
    Milano M; Collomp R
    J Oncol Pharm Pract; 2005 Dec; 11(4):145-9. PubMed ID: 16595066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of erythropoietin in neuroprotection: therapeutic perspectives.
    Grasso G; Sfacteria A; Meli F; Passalacqua M; Fodale V; Buemi M; Giambartino F; Iacopino DG; Tomasello F
    Drug News Perspect; 2007 Jun; 20(5):315-20. PubMed ID: 17878959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of Nod-like receptors alters inflammatory response to infection but does not confer protection in experimental cerebral malaria.
    Finney CA; Lu Z; LeBourhis L; Philpott DJ; Kain KC
    Am J Trop Med Hyg; 2009 May; 80(5):718-22. PubMed ID: 19407112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria.
    Rae C; McQuillan JA; Parekh SB; Bubb WA; Weiser S; Balcar VJ; Hansen AM; Ball HJ; Hunt NH
    FASEB J; 2004 Mar; 18(3):499-510. PubMed ID: 15003995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible involvement of IFN-gamma in early mortality of Plasmodium berghei NK65-infected BALB/c mice after febrifugine treatment.
    Ishih A; Nagata T; Kobayashi F; Muregi FW; Ohori K; Miyase T
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):949-58. PubMed ID: 19062681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered nucleotide receptor expression in a murine model of cerebral malaria.
    Marín-García P; Sánchez-Nogueiro J; Diez A; León-Otegui M; Linares M; García-Palencia P; Bautista JM; Miras-Portugal MT
    J Infect Dis; 2009 Oct; 200(8):1279-88. PubMed ID: 19758097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier.
    Combes V; Coltel N; Faille D; Wassmer SC; Grau GE
    Int J Parasitol; 2006 May; 36(5):541-6. PubMed ID: 16600245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic action of Plasmodium gallinaceum in chickens: brain histology and nitric oxide production by blood monocyte-derived macrophages.
    Macchi Bde M; Quaresma JA; Herculano AM; Crespo-López ME; DaMatta RA; do Nascimento JL
    Vet Parasitol; 2010 Aug; 172(1-2):16-22. PubMed ID: 20537466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of erythropoietin effects on cerebral ischemia in rats.
    Aluclu MU; Acar A; Guzel A; Bahceci S; Yaldiz M
    Neuro Endocrinol Lett; 2007 Apr; 28(2):170-4. PubMed ID: 17435667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model.
    Juul SE; McPherson RJ; Bammler TK; Wilkerson J; Beyer RP; Farin FM
    Dev Neurosci; 2008; 30(4):231-42. PubMed ID: 17960054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.
    Campos AC; Brant F; Miranda AS; Machado FS; Teixeira AL
    Neuroscience; 2015 Mar; 289():166-80. PubMed ID: 25595981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
    Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
    Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.